ReviewFrontiers in pharmacology2022

Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies.

Xiaofan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.